Department of Otolaryngology, Gyeongsang National University Hospital, Changwon, Republic of Korea.
Institute of Health Sciences, Gyeongsang National University, Jinju, Republic of Korea.
Laryngoscope. 2020 May;130(5):1218-1226. doi: 10.1002/lary.28190. Epub 2019 Jul 22.
Transoral surgery is gaining favor because it has the advantage of leaving no scar after surgery. The aim of this study was to evaluate the technical feasibility and safety of endoscope-assisted transoral accessory parotid mass excision.
Multicenter, prospective, observational study.
This study was designed as a 7-year, prospective, multicenter evaluation of endoscope-assisted transoral accessory parotid mass excision. Clinical outcomes and complications related to the procedures were evaluated in patients.
Twenty patients underwent endoscope-assisted transoral accessory parotid mass excisions, and 22 patients underwent conventional parotidectomy approach excisions. There was no significant difference with respect to overall demographic characteristics between the groups. However, the operation times were shorter in the transoral approach group (P = 0.001), and cosmetic satisfaction was much better in the transoral group (P < 0.001).
Endoscope-assisted transoral accessory parotid mass excision is a potentially safe and effective procedure with excellent outcomes.
2 Laryngoscope, 130:1218-1226, 2020.
经口手术因其术后无疤痕而受到青睐。本研究旨在评估内镜辅助经口腮腺副瘤切除术的技术可行性和安全性。
多中心、前瞻性、观察性研究。
本研究设计为内镜辅助经口腮腺副瘤切除术的 7 年前瞻性多中心评估。评估了患者的临床结果和与手术相关的并发症。
20 例患者接受了内镜辅助经口腮腺副瘤切除术,22 例患者接受了传统腮腺切除术。两组在总体人口统计学特征方面无显著差异。然而,经口入路组的手术时间更短(P = 0.001),经口组的美容满意度明显更好(P < 0.001)。
内镜辅助经口腮腺副瘤切除术是一种具有良好效果的潜在安全有效的手术。
2 级喉镜,130:1218-1226,2020。